...
机译:免疫宠物成像评估目标啮合:从ZR-89-抗HER3 MAB(GSK2849330)的实体肿瘤患者的经验
Vrije Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Univ Cambridge Dept Med Div Expt Med &
Immunotherapeut Cambridge England;
OMID Mol Imaging Consultancy Uppsala Sweden;
GlaxoSmithKline Clin Pharmacol Sci &
Study Operat Uxbridge Middx England;
Clin Pharm Adv LLC Durham NC USA;
GlaxoSmithKline Bioimaging Platform Technol &
Sci Stevenage Herts England;
GlaxoSmithKline Biopharm Prod Dev &
Supply King Of Prussia PA USA;
GlaxoSmithKline Drug Metab &
Pharmacokinet King Of Prussia PA USA;
Vrije Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Vrije Univ Amsterdam Amsterdam UMC Dept Radiol &
Nucl Med Amsterdam Netherlands;
Vrije Univ Amsterdam Amsterdam UMC Dept Radiol &
Nucl Med Amsterdam Netherlands;
Freedman Patent Harleysville PA USA;
Vrije Univ Amsterdam Amsterdam UMC Dept Radiol &
Nucl Med Amsterdam Netherlands;
GlaxoSmithKline Oncol R&
D King Of Prussia PA USA;
Vrije Univ Amsterdam Amsterdam UMC Dept Radiol &
Nucl Med Amsterdam Netherlands;
Hengrui Therapeut Inc Princeton NJ USA;
immuno-PET; HER3; antibody; target engagement; dose selection;
机译:免疫宠物成像评估目标啮合:从ZR-89-抗HER3 MAB(GSK2849330)的实体肿瘤患者的经验
机译:通过免疫PET /荧光成像评估新型单克隆抗体mAb109在无创肺腺癌诊断中的作用
机译:234 A期1期,开放标签,剂量寻找研究,用于评估 {U3 } 1287(AMG 888)(一种针对 {HER3 }的人类单克隆抗体)在晚期实体瘤患者中的安全性和耐受性
机译:药物 - 目标接合的功能测定与患者血液捕获的循环肿瘤细胞与患者进展相关
机译:工程化靶向肿瘤的聚(酰胺基胺)(PAMAM)树状大分子,以提高短干扰RNA(siRNA)通过实体瘤的渗透和细胞递送
机译:免疫PET成像评估靶标参与度:实体瘤患者89Zr-抗-HER3单抗(GSK2849330)的经验
机译:GsK2849330,aDCC和CDC优化的抗HER3 mab的生物分布的非侵入性成像评估,以及其在人肿瘤小鼠中的肿瘤巨噬细胞募集中的作用。